Sen. John Boozman Sells Off Shares of JPMorgan Chase & Co. (NYSE:JPM)

Senator John Boozman (R-Arkansas) recently sold shares of JPMorgan Chase & Co. NYSE: JPM. In a filing disclosed on March 06th, the Senator disclosed that they had sold between $1,001 and $15,000 in JPMorgan Chase & Co. stock on February 5th.

Senator John Boozman also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Sprott Lithium Miners ETF NASDAQ: LITP on 2/26/2025.
• Purchased $1,001 - $15,000 in shares of Invesco Short Term Treasury ETF NYSEARCA: TBLL on 2/26/2025.
• Sold $1,001 - $15,000 in shares of First Trust Global Tactical Commodity Strategy Fund NASDAQ: FTGC on 2/26/2025.
• Sold $1,001 - $15,000 in shares of First Trust North American Energy Infrastructure Fund NYSEARCA: EMLP on 2/26/2025.
• Purchased $1,001 - $15,000 in shares of Motorola Solutions NYSE: MSI on 2/26/2025.
• Purchased $1,001 - $15,000 in shares of Ecolab NYSE: ECL on 2/26/2025.
• Purchased $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 2/26/2025.
• Purchased $1,001 - $15,000 in shares of American Express NYSE: AXP on 2/26/2025.
• Purchased $1,001 - $15,000 in shares of NVIDIA NASDAQ: NVDA on 2/26/2025.
• Sold $1,001 - $15,000 in shares of iShares S&P 500 Growth ETF NYSEARCA: IVW on 2/26/2025.

JPMorgan Chase & Co. Trading Down 4.3 %

Shares of JPM stock traded down $10.46 during trading hours on Monday, reaching $231.82. The company's stock had a trading volume of 18,767,674 shares, compared to its average volume of 8,749,123. The company has a current ratio of 0.88, a quick ratio of 0.89 and a debt-to-equity ratio of 1.24. JPMorgan Chase & Co. has a one year low of $179.20 and a one year high of $280.25. The stock has a market capitalization of $648.18 billion, a P/E ratio of 11.74, a P/E/G ratio of 2.83 and a beta of 1.10. The firm's fifty day simple moving average is $259.41 and its 200 day simple moving average is $238.60.

Remove Ads

JPMorgan Chase & Co. (NYSE:JPM - Get Free Report) last issued its earnings results on Wednesday, January 15th. The financial services provider reported $4.81 earnings per share for the quarter, topping analysts' consensus estimates of $4.03 by $0.78. The business had revenue of $42.77 billion during the quarter, compared to analyst estimates of $41.90 billion. JPMorgan Chase & Co. had a return on equity of 16.99% and a net margin of 20.96%. JPMorgan Chase & Co.'s revenue was up 10.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.04 EPS. Equities research analysts expect that JPMorgan Chase & Co. will post 18.1 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. UBS Group lifted their price target on shares of JPMorgan Chase & Co. from $276.00 to $287.00 and gave the stock a "buy" rating in a research note on Thursday, January 16th. Barclays upped their price target on shares of JPMorgan Chase & Co. from $304.00 to $330.00 and gave the company an "overweight" rating in a research note on Thursday, January 16th. Keefe, Bruyette & Woods increased their price target on JPMorgan Chase & Co. from $257.00 to $264.00 and gave the company a "market perform" rating in a report on Thursday, January 16th. Wells Fargo & Company upped their target price on JPMorgan Chase & Co. from $240.00 to $270.00 and gave the company an "overweight" rating in a research note on Friday, November 15th. Finally, Truist Financial lifted their price objective on shares of JPMorgan Chase & Co. from $260.00 to $268.00 and gave the company a "hold" rating in a report on Thursday, January 16th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and ten have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $252.89.

Institutional Trading of JPMorgan Chase & Co.

A number of institutional investors have recently bought and sold shares of JPM. Geode Capital Management LLC raised its position in JPMorgan Chase & Co. by 1.5% during the 4th quarter. Geode Capital Management LLC now owns 59,220,603 shares of the financial services provider's stock worth $14,161,171,000 after buying an additional 876,417 shares during the last quarter. Norges Bank purchased a new position in shares of JPMorgan Chase & Co. during the fourth quarter worth $8,310,884,000. Northern Trust Corp raised its holdings in shares of JPMorgan Chase & Co. by 15.4% during the fourth quarter. Northern Trust Corp now owns 33,845,676 shares of the financial services provider's stock worth $8,113,147,000 after purchasing an additional 4,515,147 shares during the last quarter. Capital Research Global Investors raised its stake in shares of JPMorgan Chase & Co. by 9.1% during the 4th quarter. Capital Research Global Investors now owns 22,841,033 shares of the financial services provider's stock valued at $5,475,223,000 after buying an additional 1,914,049 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of JPMorgan Chase & Co. by 0.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 20,103,063 shares of the financial services provider's stock valued at $4,818,905,000 after buying an additional 71,122 shares during the period. 71.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at JPMorgan Chase & Co.

In related news, General Counsel Stacey Friedman sold 3,303 shares of the company's stock in a transaction dated Thursday, January 16th. The stock was sold at an average price of $253.94, for a total value of $838,763.82. Following the completion of the transaction, the general counsel now owns 47,620 shares of the company's stock, valued at approximately $12,092,622.80. This represents a 6.49 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Robin Leopold sold 1,250 shares of the business's stock in a transaction that occurred on Thursday, February 20th. The shares were sold at an average price of $270.09, for a total value of $337,612.50. Following the completion of the sale, the insider now owns 50,377 shares of the company's stock, valued at $13,606,323.93. This trade represents a 2.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 46,326 shares of company stock worth $12,448,445 over the last quarter. 0.79% of the stock is currently owned by insiders.

About Senator Boozman

John Boozman (Republican Party) is a member of the U.S. Senate from Arkansas. He assumed office on January 3, 2011. His current term ends on January 3, 2029. Boozman (Republican Party) ran for re-election to the U.S. Senate to represent Arkansas. He won in the general election on November 8, 2022. Boozman won re-election in 2016. He faced Democrat Conner Eldridge, Libertarian Frank Gilbert, and write-in candidate Jason Tate in the general election. Arkansas' U.S. Senate race was rated as safely Republican in 2016. Boozman began his political career in the U.S. House. He won a special election in 2001 and served in that position until his election to the Senate in 2010. Prior to his political career, Boozman worked as an optometrist. As of a 2014 analysis of multiple outside rankings, Boozman is an average Republican member of Congress, meaning he will vote with the Republican Party on the majority of bills. Below is an abbreviated outline of Boozman's academic, professional, and political career: 2011-Present: U.S. Senator from Arkansas 2001-2011: U.S. Representative from Arkansas 1977: Graduated from Southern College of Optometry

JPMorgan Chase & Co. Company Profile

JPMorgan Chase & Co is a financial holding company, which engages in the provision of financial and investment banking services. The firm offers a range of investment banking products and services in all capital markets, including advising on corporate strategy and structure, capital raising in equity and debt markets, risk management, market making in cash securities and derivative instruments, and brokerage and research.